ORTEXORTEX News
Tracking CRI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CR
Trader NoteCRI

Carter's Beats Big, But the Stock Went In Before the Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 6 May 2026, 19:57

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CRI arrived at its Q1 2026 earnings report having already shed more than 11% on the week, a bruising move that made Tuesday morning's numbers land with extra force.

Q1 adjusted EPS came in at $0.39, against a Street estimate of just $0.13. Revenue of $681M topped forecasts of $661M by 3%, and the retail segment delivered 12.8% sales growth. Q2 guidance for adjusted EPS of $0.02–$0.06 also cleared the consensus bar, which had pencilled in a loss. The stock bounced roughly 14% intraday on the print — a sharp reversal that underscored just how much pessimism had built into the share price ahead of the release. That setup was the tension of the week: a stock that had been heavily sold down heading into a quarter it then handily beat.

The short interest picture adds texture to that pre-print pressure. Shorts amount to 7.6% of free float — meaningful for a consumer apparel name — and had been climbing through April, rising 3.3% over the past week to roughly 2.76 million shares. The bulk of that build occurred in the mid-April period, when short interest briefly topped 3.2 million shares before pulling back about 14% heading into May. Borrowing costs remain very cheap at 0.44% annualised, having drifted lower over the past month despite the modest weekly tick higher. Borrow availability is generous — well above 1,000% of existing short interest — meaning there is no squeeze pressure at all in the lending market. Shorts faced no friction going in and face none coming out: the Q1 rally will be a mark-to-market loss for any position that wasn't closed before the print, not a forced cover.

Options traders were tilting toward calls heading into earnings day, with the put/call ratio at 0.30 — below its 20-day average of 0.33 and sitting near the lower end of its 52-week range (low: 0.22, high: 0.74). The mild bullish skew in positioning is consistent with a market that had started hedging up rather than hedging down, even as the stock was under pressure. It wasn't extreme call-buying — the z-score of -0.63 is barely outside normal — but the directional lean proved correct.

The analyst backdrop heading into the print was cautiously negative, with several well-known firms carrying Underweight or Sell ratings. Wells Fargo lifted its target from $28 to $33 (Underweight) just days before the Q1 release — a modest upgrade that still sat below the pre-release share price. Goldman Sachs held a Sell with a $29 target as recently as January. Citigroup stood out as a more optimistic outlier, having upgraded to Buy in January with a $50 target — considerably above where the stock was trading. The consensus mean target of $39 implies roughly 18% return potential from recent levels, though that figure was calculated before the post-earnings bounce. The analyst consensus arriving into earnings was split enough that the big EPS surprise forced a reassessment rather than confirming a consensus view. The stock's EPS momentum factor ranks in the 80th–81st percentile over both 30 and 90-day windows, suggesting the trend of beating estimates has been consistent; the analyst recommendation divergence score ranks in the 94th percentile, capturing how sharply the Street is split.

The other major headline this week was a leadership change: CRI appointed Sharon Price John — a brand and retail veteran — as incoming President and CEO, effective June 15. The CEO role had been in transition, with the prior chief having sold 10,957 shares at $35.91 in early April — a modest transaction that reads more like routine selling than a signal. CFO Richard Westenberger also sold smaller tranches in March and April at comparable prices. Net insider selling over the past 90 days totals roughly 36,850 shares worth approximately $1.4M — all small individually, and none carry a significance score above the minimum threshold. The leadership transition, rather than the insider selling, is the more consequential corporate development. RWWM, Inc. — the third-largest institutional holder — trimmed its position by close to 1.9 million shares in the most recent reporting period, bringing its stake to roughly 2.6 million shares or 7% of outstanding. That is the most notable ownership shift in the top-holder list.

What to watch next: with Q1 firmly in the books and the new CEO not yet in the seat until mid-June, the May 13 next-event date bears monitoring for any additional company communications, while the market will be assessing how much of the post-print bounce is durable given the ongoing consumer spending uncertainty that had pressured apparel names broadly through April.

Stocks in this article

See the live data behind this article on ORTEX.

Open CRI on ORTEX →

How this article was generated

Generated
6 May 2026, 19:58
Data as of
6 May 2026, 19:57
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.